CONSOLIDATED STATEMENT OF CASH FLOWS
Year ended December 31,
|
|
|
|
| (in thousands of US dollars) |
1995 |
1996 |
1997 |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
| Net income |
526,478 |
625,544 |
406,554 |
| Add (deduct) non-cash items: |
|
|
|
| Depreciation and amortization |
392,390 |
535,908 |
608,123 |
| Gain on disposal of investment |
-- |
(7,263) |
-- |
| Other non-cash items |
(8,707) |
7,298 |
19,015 |
| Minority interest in net income of subsidiaries |
(584) |
(1,666) |
(2,398) |
| Deferred income tax |
(6,365) |
58,515 |
(3,157) |
| Changes in assets and liabilities: |
|
|
|
| Trade receivables |
(126,603) |
(71,774) |
(74,721) |
| Inventories |
(91,412) |
(80,517) |
(149,642) |
| Trade payables |
17,005 |
(38,019) |
73,790 |
| Other assets and liabilities, net |
122,927 |
(47,359) |
106,227 |
|
|
|
|
| Net cash from operating activities |
825,129 |
980,667 |
983,791 |
|
|
|
|
| Cash flows from investing activities: |
|
|
|
| Payment for purchases of tangible assets |
(1,001,936) |
(1,125,205) |
(1,035,434) |
| Proceeds from sale of investment |
-- |
8,420 |
-- |
| Other investing activities |
2,868 |
(5,297) |
(16,059) |
| Investment in marketable securities (net) |
5 |
(196) |
4,483 |
|
|
|
|
| Net cash used in investing activities |
(999,063) |
(1,122,278) |
(1,047,010) |
|
|
|
|
| Cash flows from financing activities: |
|
|
|
| Proceeds from issuance of long-term debt |
11,741 |
84,623 |
250,759 |
| Repayment of long-term debt |
(96,202) |
(54,085) |
(80,238) |
| Increase (decrease) in short-term facilities |
165,298 |
(106,239) |
68,869 |
| Capital increase |
391,321 |
16,671 |
9,669 |
|
|
|
|
| Net cash from (used in) financing activities |
472,158 |
(59,030) |
249,059 |
|
|
|
|
| Effect of changes in exchange rates |
(1,412) |
(1,509) |
(35,579) |
|
|
|
|
| Net cash increase (decrease) |
296,812 |
(202,150) |
150,261 |
|
|
|
|
| Cash and cash equivalents at beginning of the year |
457,234 |
754,046 |
551,896 |
|
|
|
|
| Cash and cash equivalents at end of the year |
754,046 |
551,896 |
702,157 |
|
|
|
|
The accompanying notes are an integral part of these financial statements


|